Abstract:Importance: Nodal staging for laryngohypopharyngeal cancers is based primarily on size and laterality, with less value placed on absolute number of metastatic lymph nodes (LNs). We are aware of no studies to date that have specifically addressed the prognostic effect of quantitative nodal burden in larynx or hypopharynx malignancies.Objective: To assess the independent impact of quantitative metastatic LN burden on mortality risk.Design, Setting, and Participants: Univariate and multivariable models were constructed to evaluate the association between patients' number of metastatic LNs and their survival, adjusting for factors such as nodal size, laterality, extranodal extension, margin status, and adjuvant treatment. Participants were patients with squamous cell carcinoma of the larynx or hypopharynx undergoing upfront surgical resection for curative intent at a US hospital between 2004 and 2013, as identified in the National Cancer Database. A neck dissection of a minimum of 10 LNs was required.Main Outcomes and Measures: Overall survival.Results: Overall, 8351 cases were included (mean [SD] age, 61 [10.1] years; 6499 men [77.8%]; 4710 patients with metastatic LNs and 3641 with no metastatic LNs). Mortality risk escalated continuously without plateau as number of metastatic nodes increased, with the hazard per node (hazard ratio [HR], 1.19; 95% CI, 1.16-1.23; P < .001) most pronounced up to 5 positive LNs. Extranodal extension was also associated with increased mortality (HR, 1.34; 95% CI, 1.13-1.59; P < .001). Increasing number of nodes examined was associated with improved survival, albeit to a lesser degree (per 10 LNs: HR, 0.97; 95% CI, 0.96-0.98; P < .001) and without a detectable change point. Other nodal factors, including nodal size, contralateral LN involvement (TNM stage N2c), and lower LN involvement (levels 4-5), were not associated with mortality in multivariable models when accounting for number of positive LNs. A novel, parsimonious nodal staging system derived by recursive partitioning analysis exhibited greater concordance with survival than the TNM staging system outlined in the American Joint Committee on Cancer's AJCC Staging Manual, 8th edition.Conclusions and Relevance: The number of metastatic nodes is a predominant independent factor associated with mortality in hypopharyngeal and laryngeal cancers. Moreover, standard nodal staging factors like LN size and contralaterality have no independent prognostic value when accounting for positive LN number. Deeper integration of quantitative metastatic nodal disease may simplify staging and better triage the need for adjuvant therapy.

Metastatic lymph node burden predictive of survival in patients undergoing primary surgery for laryngeal and hypopharyngeal cancer

Association of Quantitative Metastatic Lymph Node Burden With Survival in Hypopharyngeal and Laryngeal Cancer

Number of positive lymph nodes better predicts survival for oral cavity cancer

The pattern of lymph node metastasis in peripheral pulmonary nodules patients and risk prediction models

Predictive Risk Factors for Lymph Node Metastasis in Patients with Small Size Non-Small Cell Lung Cancer.

The Prognostic Importance of the Number of Metastatic Lymph Nodes for Patients Undergoing Curative Resection Followed by Adjuvant Chemoradiotherapy for Extrahepatic Bile Duct Cancer

Quantitative Metastatic Lymph Node Regions on Magnetic Resonance Imaging Are Superior to AJCC N Classification for the Prognosis of Nasopharyngeal Carcinoma

Positive lymph node ratio predicts adverse prognosis for patients with lymph nodes metastatic hypopharyngeal squamous cell carcinoma after primary surgery

Comparative Analysis of Methodologies for Predicting Overall Survival in Patients with Non‐small Cell Lung Cancer Based on the Number and Rate of Resected Positive Lymph Nodes: A Study Based on the SEER Database for 2010 Through 2019

Evaluation of Four Lymph Node Classifications for the Prediction of Survival in Hilar Cholangiocarcinoma

Lymph node ratio as a survival predictor for head and neck squamous cell carcinoma with multiple adverse pathological features

Comprehensive Analysis of Prognostic Value of Lymph Node Staging Classifications in Patients with Head and Neck Squamous Cell Carcinoma after Cervical Lymph Node Dissection

The Number of Metastatic Lymph Nodes is More Predictive of Prognosis Than Location-Based N Stage for Nonsmall Cell Lung Cancer: a Retrospective Cohort Study.

Is the burden of metastatic lymph node stations a prognostic factor in patients with resected lung cancer?

Which N Descriptor is More Predictive of Prognosis in Resected Non-small Cell Lung Cancer the Number of Involved Nodal Stations or the Location-Based Pathological N Stage?

Prognostic value of lymph node ratio in patients with non-metastatic cervical cancer treated with radical hysterectomy: A population-based study

The Assessment of the Optimal Number of Examined Lymph Nodes and Prognostic Models Based on Lymph Nodes for Predicting Survival Outcome in Patients with Stage N3b Gastric Cancer

The N-Classification for Esophageal Cancer Staging: Should it be Based on Number, Distance, or Extent of the Lymph Node Metastasis?

The Number of Resected Lymph Nodes (nlns) Combined with Tumor Size As a Prognostic Factor in Patients with Pathologic N0 and Nx Non-Small Cell Lung Cancer.

Number of positive lymph nodes and lymph node ratio predict recurrence and survival in hypopharyngeal cancer based on SEER database and validation of real-world data

Prognostic Accuracy of Different Lymph Node Staging System in Predicting Overall Survival in Stage IV Colon Cancer.